Related Experiment Video

Updated: Aug 8, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Update on HER-2 as a target for cancer therapy: alternative strategies for targeting the epidermal growth factor

W J Gullick1

  • 1Department of Biosciences, University of Kent at Canterbury, Canterbury, Kent, UK. W.J.Gullick@ukc.ac.uk

Breast Cancer Research : BCR
|December 12, 2001
PubMed

Insights

The epidermal growth factor (EGF) system drives cancer cell growth and is a key target for new cancer therapies. Understanding specific EGF mechanisms is crucial for developing effective chemotherapy strategies with manageable side effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The epidermal growth factor (EGF) family ligands and receptors are critical regulators of cell division, differentiation, and motility.
  • Their aberrant signaling is implicated in the initiation and progression of various human cancers.
  • The precise mechanisms of EGF pathway involvement in tumorigenesis differ across cancer types.

Purpose of the Study:

  • To review the role of the EGF system in cancer.
  • To discuss the EGF system as a therapeutic target in oncology.
  • To highlight the challenges and considerations for developing targeted chemotherapy strategies.

Main Methods:

  • Literature review of studies on EGF signaling in cancer.
  • Analysis of current and emerging targeted chemotherapy approaches.
  • Evaluation of clinical trial data for EGF-targeted therapies.

Main Results:

  • The EGF system plays a significant role in promoting and maintaining cancer cell transformation.
  • Targeting the EGF pathway offers a promising avenue for novel cancer treatments.
  • Various therapeutic strategies targeting the EGF system are in clinical development.

Conclusions:

  • The EGF system is a validated and important target for cancer therapy.
  • The efficacy of EGF-targeted therapies depends on the specific underlying molecular mechanisms.
  • Strategies must address potential drug resistance and varying side effect profiles.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...